List of insiders holdings for HERON THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner | 2014-02-14 16:32:42 | 35,248,555 0 | 35,248,555 | Form 13G |
| Rubric Capital Management LP Rosen David Efraim 10% Owner | 2023-07-25 16:15:59 | 0 26,713,503 | 26,713,503 | Form 3 |
| Baker / Tisch Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner | 2011-07-06 17:59:45 | 20,526,568 0 | 20,526,568 | Form 13D |
| Baker Biotech Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner | 2011-07-06 17:59:45 | 20,526,568 0 | 20,526,568 | Form 13D |
| Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2011-07-06 17:59:45 | 20,526,568 0 | 20,526,568 | Form 13D |
| 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2011-07-06 17:59:45 | 20,526,568 0 | 20,526,568 | Form 13D |
| Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2011-07-06 17:59:45 | 20,526,568 0 | 20,526,568 | Form 13D |
| Morgan Adam Director | 2024-01-19 21:04:11 | 135,512 6,986,744 | 7,122,256 | Form 4 |
| BARR JOHN Vice President of R&D | 2011-07-12 17:23:46 | 7,000,000 0 | 7,000,000 | Form 4 |
| Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 | 2023-02-08 18:26:00 | 0 4,500,000 | 4,500,000 | Form 3 |
| TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner | 2023-02-14 16:00:28 | 3,756,694 0 | 3,756,694 | Form 13G |
| ADAM MICHAEL A Chief Operating Officer | 2013-02-12 20:34:35 | 1,000,000 0 | 1,000,000 | Form 4 |
| Quart Barry D Chief Executive Officer | 2023-01-20 17:10:01 | 850,000 0 | 850,000 | Form 4 |
| KOTLER KEVIN Director | 2023-03-02 16:13:38 | 265,151 540,000 | 805,151 | Form 3 |
| Savitr Capital LLC Exiting 10% holder | 2016-01-28 17:08:48 | 772,000 0 | 772,000 | Form 13G |
| SPCH LLC Midler Andrew R Exiting 10% holder | 2016-01-28 17:09:23 | 772,000 0 | 772,000 | Form 13G |
| Whelan John CFO | 2013-07-19 19:21:59 | 647,454 0 | 647,454 | Form 4 |
| TURNBULL GREG Director | 2012-05-31 14:09:23 | 500,000 0 | 500,000 | Form 4 |
| GODDARD PAUL Chairman | 2012-05-31 14:11:39 | 500,000 0 | 500,000 | Form 4 |
| Collard Craig A Chief Executive Officer | 2024-04-19 16:34:56 | 469,746 0 | 469,746 | Form 4 |
| Rosen Robert President | 2018-12-18 20:09:58 | 300,000 0 | 300,000 | Form 4 |
| PRENTKI RONALD J President & CEO | 2010-02-19 13:27:23 | 250,000 0 | 250,000 | Form 4 |
| ROSENBLATT TOBY Director | 2010-05-26 13:55:15 | 210,234 0 | 210,234 | Form 4 |
| ZERBE ROBERT L MD Director | 2010-05-26 13:56:04 | 202,072 0 | 202,072 | Form 4 |
| Rodriguez Susan Director | 2024-01-19 21:04:50 | 152,915 0 | 152,915 | Form 4 |
| Dissanaike Sharmila Director | 2024-01-19 21:02:44 | 152,915 0 | 152,915 | Form 4 |
| Clendeninn Neil James SVP & Chief Medical Officer | 2015-10-13 21:21:46 | 150,000 0 | 150,000 | Form 4 |
| Christian Waage Director | 2024-01-19 21:05:33 | 149,865 0 | 149,865 | Form 4 |
| Johnson Craig A Director | 2024-01-19 21:03:27 | 149,505 0 | 149,505 | Form 4 |
| Duarte Ira EVP, Chief Financial Officer | 2024-04-19 17:48:06 | 145,867 0 | 145,867 | Form 4 |
| Forbes William P EVP, Chief Development Officer | 2024-04-19 17:02:52 | 140,989 0 | 140,989 | Form 4 |
| DAVIS STEPHEN Director | 2022-12-20 17:19:23 | 129,192 0 | 129,192 | Form 4 |
| Retzios Anastassios D. VP of Clinical Development | 2008-01-17 21:47:32 | 114,700 0 | 114,700 | Form 4 |
| HOFFMAN ROBERT CFO & SVP, Finance | 2019-12-23 16:28:00 | 100,000 0 | 100,000 | Form 4 |
| RIEPENHAUSEN PETER Director | 2008-05-30 18:16:46 | 51,567 44,833 | 96,400 | Form 4 |
| DRURY STEPHEN A Director | 2006-08-14 14:38:27 | 1429 84,712 | 86,141 | Form 4 |
| POYHONEN JOHN President & CCO | 2023-04-17 17:27:57 | 82,084 0 | 82,084 | Form 4 |
| WINGER DENNIS L Director | 2006-08-14 14:40:09 | 69,544 0 | 69,544 | Form 4 |
| MANHARD KIMBERLY EVP, Drug Development | 2023-04-17 17:26:14 | 63,766 0 | 63,766 | Form 4 |
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-17 17:51:53 | 63,376 0 | 63,376 | Form 4 |
| Peraza Lisa VP, Chief Accounting Officer | 2024-01-19 21:01:56 | 47,924 0 | 47,924 | Form 4 |
| Gelder Mark S. MD SVP & Chief Medical Officer | 2014-12-15 20:59:55 | 45,000 0 | 45,000 | Form 4 |
| Marshall Paul SVP, Technical Operations | 2016-03-23 15:07:10 | 45,000 0 | 45,000 | Form 4 |
| OCONNELL MICHAEL Chief Executive Officer | 2006-01-12 18:45:31 | 45,000 0 | 45,000 | Form 4 |
| TAYLOR ARTHUR T Director | 2008-05-30 19:14:02 | 35,750 0 | 35,750 | Form 4 |
| WHITEFORD STEPHEN V.P., Finance & CFO | 2006-12-18 18:15:32 | 15,000 0 | 15,000 | Form 4 |
| Drazba Brian G. VP, Finance & CFO | 2016-12-23 16:03:07 | 4913 0 | 4913 | Form 4 |
| TANG KEVIN C Former Director Director | 2021-02-16 16:18:45 | 0 3445 | 3445 | Form 5 |